Search Within

Stephen D Nimer

  1. "Myeloma"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (8)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Department of Medicine (31)
  3. Hematologic Malignancies, Division of (31)
  4. Myeloma (31)
  5. Survivorship Research (15)
  6. Bone Marrow Transplant (14)

More Groups

People
  1. Hani Hassoun (31)
  2. Raymond Comenzo (22)
  3. Adam Cohen (15)
  4. Lilian Reich (15)
  5. Martin Fleisher (15)
  6. Heather Landau (14)

More People

Years
  1. 2012 (1)
  2. 2011 (1)
  3. 2010 (3)
  4. 2009 (6)
  5. 2008 (5)
  6. 2007 (3)

More Years

Publications
  1. Blood (18)
  2. Amyloid (3)
  3. Bone Marrow Transplantation (2)
  4. British Journal of Haematology (2)
  5. Journal of Clinical Oncology (2)
  6. Clinical Lymphoma and Myeloma (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Taylor & Francis Group (4)
  3. Nature Publishing Group (3)
  4. American Society of Clinical Oncology (2)
  5. John Wiley & Sons (2)
  6. CRC Press/Taylor & Francis Group (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save
  • Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Journal Article

    Landau, H.; Hassoun, H.; Bello, C.; Hoover, E.; Riedel, E. R.; Nimer, S. D.; Comenzo, R. L.
    Amyloid (2011)

    Fulltext@MSK | Save
  • Maintained hematologic and organ responses at two years following stem cell transplant in systemic light-chain amyloidosis (AL) using short-course bortezomib and dexamethasone consolidation therapy
    Meeting Abstract

    Landau, H.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Lesokhin, A.; Lendvai, N.; Cohen, A.; Nimer, S.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Outcomes following salvage autologous stem cell transplant for multiple myeloma
    Meeting Abstract

    Fein, D. E.; Hassoun, H.; Comenzo, R. L.; Lesokhin, A.; Lendvai, N.; Chung, D.; Cohen, A.; Rosenzweig, M. A.; Chimento, D.; Jia, X.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis
    Meeting Abstract

    Landau, H.; Hassoun, H.; Bello, C.; Hoover, E.; Jia, X.; Riedel, E. R.; Nimer, S. D.; Comenzo, R. L.
    Amyloid (2010)

    Fulltext@MSK | Save
  • FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
    Meeting Abstract

    Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in patients with light-chain amyloidosis (AL)
    Meeting Abstract

    Landau, H. J.; Hoffman, J.; Hassoun, H.; Elizabeth, H.; Riedel, E.; Nimer, S. D.; Cohen, A.; Comenzo, R. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Outcome of patients with multiple myeloma treated with autologous stem cell transplantation in the era of novel therapies
    Meeting Abstract

    Hassoun, H.; Landau, H.; Surti, C.; Adel, N. G.; Jia, X. Y.; Riedel, E. R.; Manisha, B.; Comenzo, R.; Lesokhin, A.; Chung, D. J.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Cisplatin-based chemotherapy is associated with an unacceptably high incidence of thromboembolic events: A large retrospective analysis
    Meeting Abstract

    Moore, R. A.; Adel, N. G.; Bhutani, M.; Tabbara, N. E.; Landau, H.; Nimer, S. D.; Feldman, D. R.; Hassoun, H.
    Blood (2009)

    Fulltext@MSK | Save
  • Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; more...
    Blood (2009)

    Fulltext@MSK | Save